The benefits of increasing surface area to volume ratio have long been realized by the pharmaceutical industry for addressing the solubility limited oral bioavailability. In the recent past various excipients that include but not limited to polymers and lipids are used to engineer nanostructures tha
Formulating poly(lactide-co-glycolide) particles for plasmid DNA delivery
β Scribed by Aiman O. Abbas; Maureen D. Donovan; Aliasger K. Salem
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 162 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
β¦ Synopsis
Biodegradable poly(lactide-co-glycolide) (PLGA) particles have shown significant potential for sustained and targeted delivery of several pharmaceutical agents, including plasmid DNA (pDNA). Here, we survey current approaches to PLGA particle preparation for pDNA delivery and discuss recent progress on optimizing formulation development.
π SIMILAR VOLUMES
## Abstract When designing a nonviral gene delivery system based on polymeric nanoparticles (NPs), it is important to keep in mind obstacles associated with future clinical applications. Simplifying the procedure of NPs production and taking toxicity into account are the most important issues that
## Abstract Biodegradable, superparamagnetic microparticles and nanoparticles of poly(lactideβ__co__βglycolide) (PLGA) and cellulose were designed, fabricated, and characterized for magnetic cell labeling. Monodisperse nanocrystals of magnetite were incorporated into microparticles and nanoparticle